Dianthus Therapeutics (DNTH) Other Non-Current Assets (2017 - 2025)
Historic Other Non-Current Assets for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $9.3 million.
- Dianthus Therapeutics' Other Non-Current Assets rose 394148.47% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 394148.47%. This contributed to the annual value of $9.6 million for FY2024, which is 73440.21% up from last year.
- Latest data reveals that Dianthus Therapeutics reported Other Non-Current Assets of $9.3 million as of Q3 2025, which was up 394148.47% from $9.2 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Other Non-Current Assets registered a high of $9.6 million during Q4 2024, and its lowest value of $60000.0 during Q3 2022.
- Its 4-year average for Other Non-Current Assets is $2.7 million, with a median of $229000.0 in 2024.
- As far as peak fluctuations go, Dianthus Therapeutics' Other Non-Current Assets plummeted by 9662.92% in 2023, and later skyrocketed by 1381060.61% in 2025.
- Dianthus Therapeutics' Other Non-Current Assets (Quarter) stood at $121000.0 in 2022, then soared by 853.72% to $1.2 million in 2023, then surged by 734.4% to $9.6 million in 2024, then dropped by 3.88% to $9.3 million in 2025.
- Its Other Non-Current Assets stands at $9.3 million for Q3 2025, versus $9.2 million for Q2 2025 and $7.6 million for Q1 2025.